A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

Clinical trial NCT04978337 · TERMINATED

Trial details

NCT number: NCT04978337
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2021-11-17
Primary completion: 2022-03-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.